Jackow J, Rami A, Hayashi R, Hansen C, et al. Targeting the Jak/Signal Transducer and Activator of Transcription 3 Pathway with Ruxolitinib in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa-Squamous Cell Carcinoma. J Invest Dermatol 2021;141:942-946.
PMID: 33069729